PureTech Health (PRTC) Non-Current Deferred Tax Liability (2019 - 2023)
PureTech Health (PRTC) reported Non-Current Deferred Tax Liability of $1.9 million for Q4 2023, down 97.88% quarter-over-quarter from $89.8 million in Q4 2021.
PureTech Health (PRTC) Non-Current Deferred Tax Liability (2019 - 2023) Analysis & Trends
PureTech Health (PRTC) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $1.9 million in Q4 2023.
- Non-Current Deferred Tax Liability for Q4 2023 came in at $1.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $1.9 million (changed N/A YoY), and the FY2023 annual result was $1.9 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability declined to $1.9 million in Q4 2023 per PRTC's latest filing, from $89.8 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $115.4 million in Q4 2019 and troughed at $1.9 million in Q4 2023.
- A 4-year average of $78.9 million and a median of $99.2 million in 2020 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2020 and 2021: Non-Current Deferred Tax Liability fell 5.91% in 2020, then declined 17.36% in 2021.
- A 4-year view of Non-Current Deferred Tax Liability shows it stood at $115.4 million in 2019, then fell by 5.91% to $108.6 million in 2020, then decreased by 17.36% to $89.8 million in 2021, then plunged by 97.88% to $1.9 million in 2023.
- Business Quant data shows PRTC's Non-Current Deferred Tax Liability at $1.9 million in Q4 2023, $89.8 million in Q4 2021, and $108.6 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.90 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Dec 31, 2021 | 89.77 Mn |
| Dec 31, 2021 | 89.77 Mn |
| Dec 31, 2020 | 108.63 Mn |
| Dec 31, 2020 | 108.63 Mn |
| Dec 31, 2019 | 115.45 Mn |
| Dec 31, 2019 | 115.45 Mn |